FF:13099-140D3: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
| | |ancestors_in_anatomy_facet=UBERON:0000061,UBERON:0000310,UBERON:0000465,UBERON:0000468,UBERON:0000475,UBERON:0000915,UBERON:0001062,UBERON:0001443,UBERON:0005482 | ||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000063,CL:0000066,CL:0000255,CL:0000548 | |ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000063,CL:0000066,CL:0000255,CL:0000548 | ||
|ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:14566,DOID:1612,DOID:162,DOID:299,DOID:305,DOID:4,DOID:5093,DOID:7 | |ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:14566,DOID:1612,DOID:162,DOID:299,DOID:305,DOID:4,DOID:5093,DOID:7 | ||
| | |comment= | ||
|created_by= | |||
|creation_date= | |||
|def= | |||
|fonse_cell_line=FF:0100816,FF:0101120 | |fonse_cell_line=FF:0100816,FF:0101120 | ||
|fonse_cell_line_closure=FF:0100816,FF:0101120 | |fonse_cell_line_closure=FF:0100816,FF:0101120 | ||
Line 66: | Line 33: | ||
|fonse_treatment=EFO:0000369,FF:0000330,FF:0000428,FF:13099-140D3 | |fonse_treatment=EFO:0000369,FF:0000330,FF:0000428,FF:13099-140D3 | ||
|fonse_treatment_closure=EFO:0000369,FF:0000330,FF:0000428,FF:13099-140D3 | |fonse_treatment_closure=EFO:0000369,FF:0000330,FF:0000428,FF:13099-140D3 | ||
|has_quality= | |has_quality= | ||
|id=FF:13099-140D3 | |||
|is_a=EFO:0002091;;FF:0000210;;FF:0000428 | |is_a=EFO:0002091;;FF:0000210;;FF:0000428 | ||
|name=MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | |||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|part_of= | |part_of= | ||
|profile_cagescan=,,, | |||
|profile_hcage=CNhs12477,LSID916,release011,COMPLETED | |||
|profile_rnaseq=,,, | |||
|profile_srnaseq=,,, | |||
|rna_box=140 | |||
|rna_catalog_number= | |||
|rna_concentration=0.67 | |||
|rna_extraction_protocol=Repurified by minelute | |||
|rna_lot_number= | |||
|rna_od260/230=1.98 | |||
|rna_od260/280=2.02 | |||
|rna_position=D3 | |||
|rna_rin= | |||
|rna_sample_type= | |||
|rna_tube_id=140D3 | |||
|rna_weight_ug=6.68 | |||
|sample_age= | |||
|sample_cell_catalog= | |||
|sample_cell_line=MCF7 | |||
|sample_cell_lot= | |||
|sample_cell_type=mammary gland epithelial cell | |||
|sample_collaboration=Mariko Okada Hatakeyama (RIKEN RCAI) | |||
|sample_company= | |||
|sample_description= | |||
|sample_dev_stage= | |||
|sample_disease= | |||
|sample_donor(cell lot)=rep2 | |||
|sample_ethnicity= | |||
|sample_experimental_condition=MCF7 breast cancer cell line response to Epidermal Growth Factor 1 | |||
|sample_id=13099 | |||
|sample_note= | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=breast | |||
|top_motifs= | |||
}} | }} |
Revision as of 15:26, 21 March 2012
Name: | MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>dataNo results for this sample
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12477This sample isn't target for the analysis
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12477This sample isn't target for the analysis
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs12477
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000210 human sample
FF:0000428 human MCF7 breast cancer cell line 30min after EGF1 treatment sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000066 (epithelial cell)
0000255 (eukaryotic cell)
0000548 (animal cell)
DOID: Disease
0050686 (organ system cancer)
0050687 (cell type cancer)
14566 (disease of cellular proliferation)
1612 (breast cancer)
162 (cancer)
299 (adenocarcinoma)
305 (carcinoma)
4 (disease)
5093 (thoracic cancer)
7 (disease of anatomical entity)
UBERON: Anatomy
0000061 (anatomical structure)
0000310 (breast)
0000465 (material anatomical entity)
0000468 (multi-cellular organism)
0000475 (organism subdivision)
0000915 (thoracic segment of trunk)
0001062 (anatomical entity)
0001443 (chest)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA